| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021981351 |
| P356 | DOI | 10.1186/1476-4598-9-1 |
| P932 | PMC publication ID | 2818691 |
| P698 | PubMed publication ID | 20051109 |
| P5875 | ResearchGate publication ID | 40849962 |
| P2093 | author name string | Lawrence S Young | |
| Jianyong Shao | |||
| John D O'Neil | |||
| John R Arrand | |||
| Christopher W Dawson | |||
| Thomas J Owen | |||
| Chunfang Hu | |||
| Kathryn L Date | |||
| Robert Valentine | |||
| Khilan M Shah | |||
| Sonia P Maia | |||
| P2860 | cites work | Hostile takeovers: viral appropriation of the NF-kB pathway | Q22241900 |
| Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1) | Q24297420 | ||
| Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase | Q24309461 | ||
| Inhibition of IkappaB kinase by vaccinia virus virulence factor B14 | Q24312867 | ||
| Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice | Q24562912 | ||
| Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma | Q28191706 | ||
| HAUSP/USP7 as an Epstein-Barr virus target | Q28288651 | ||
| Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice | Q28594944 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation | Q29617419 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33835021 | ||
| Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth | Q33953070 | ||
| Epstein-Barr virus and oncogenesis: from latent genes to tumours | Q34221194 | ||
| Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. | Q34332147 | ||
| Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 | ||
| NF-kappaB and virus infection: who controls whom | Q35139535 | ||
| Viral appropriation of apoptotic and NF-kappaB signaling pathways | Q35719506 | ||
| Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2 | Q35852995 | ||
| Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB | Q35913517 | ||
| NF-kappaB and cancer: mechanisms and targets | Q36468005 | ||
| Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. | Q36610569 | ||
| The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated | Q36699468 | ||
| Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells | Q36734903 | ||
| Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes | Q37127891 | ||
| Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. | Q37595549 | ||
| Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis | Q39539644 | ||
| Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. | Q39549562 | ||
| Mapping EBNA-1 domains involved in binding to metaphase chromosomes. | Q39550682 | ||
| Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata | Q39582149 | ||
| Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro | Q39927855 | ||
| Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. | Q40047929 | ||
| Interplay between E-box and NF-kappaB in regulation of A20 gene by DRB sensitivity-inducing factor (DSIF). | Q40061994 | ||
| Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways | Q40135893 | ||
| C/EBP beta blocks p65 phosphorylation and thereby NF-kappa B-mediated transcription in TNF-tolerant cells | Q40265408 | ||
| Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype | Q40736254 | ||
| Nuclear factor kappaB subunits induce epithelial cell growth arrest | Q41756058 | ||
| NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. | Q45982548 | ||
| Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression | Q46728299 | ||
| Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas | Q70061763 | ||
| Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells | Q77304089 | ||
| P921 | main subject | Epstein–Barr virus | Q6900 |
| phosphorylation | Q242736 | ||
| NF-κB | Q411114 | ||
| P304 | page(s) | 1 | |
| P577 | publication date | 2010-01-05 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation | |
| P478 | volume | 9 |
| Q33710698 | Attenuated Nuclear Factor Kappa B Activity by E7 Protein of Human Papillomavirus Type 2 in Human Epidermal Keratinocytes |
| Q39123741 | Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. |
| Q27003831 | Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival |
| Q39455578 | Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma |
| Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
| Q39626966 | Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis |
| Q41704824 | Differential response of porcine immature monocyte-derived dendritic cells to virulent and inactivated transmissible gastroenteritis virus |
| Q38597231 | EBNA1. |
| Q55003883 | EBV based cancer prevention and therapy in nasopharyngeal carcinoma. |
| Q92998898 | EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells |
| Q55273418 | Epstein Barr Virus Infection Affects Function of Cytotoxic T Lymphocytes in Patients with Severe Aplastic Anemia. |
| Q39629572 | Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin |
| Q34261764 | Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer |
| Q28082701 | Epstein-Barr virus latent genes |
| Q34382544 | Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells |
| Q39402421 | Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. |
| Q38597254 | Immune Evasion by Epstein-Barr Virus |
| Q39002181 | Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma |
| Q39297691 | Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK |
| Q37907354 | Inhibitory kappa B kinases as targets for pharmacological regulation |
| Q28709497 | Modulation of NF-κB signalling by microbial pathogens |
| Q54115911 | NF-κB Signaling Regulates Epstein-Barr Virus BamHI-Q-Driven EBNA1 Expression. |
| Q37374081 | NF-κB as a Target for Oncogenic Viruses |
| Q35606754 | NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells |
| Q36413217 | Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas |
| Q26852071 | Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus |
| Q37972201 | Role of EBNA1 in NPC tumourigenesis |
| Q47112739 | Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients. |
| Q38166365 | The Epstein-Barr Virus EBNA1 Protein |
| Q64070234 | The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes |
| Q47425387 | The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers. |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q58777919 | Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells |
| Q26823898 | Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients |
| Q41425937 | circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family |
Search more.